KALA BIO Receives $6M Investment and Appoints New CEO
KALA BIO secures $6M investment from David E. Lazar, names him CEO and Chairman, and plans to continue developing eye disease therapies after CHASE trial setbacks.
NOTRELOAD AI
RBC Capital Upgrades Neumora Therapeutics to Outperform
RBC Capital raises Neumora Therapeutics to Outperform, citing new growth opportunities beyond neurology and promising early data in multiple markets.
Goldman Sachs Upgrades Chime to Buy with Strong Upside Potential
Goldman Sachs upgrades Chime to Buy with a $27 price target, citing strong take-rate potential from the new Chime Card and revenue diversification strategy.
Biotech Meets Bitcoin: Apimeds and MindWave Merge with $100M Backing
Apimeds Pharmaceuticals merges with MindWave Innovations, combining pain management biotech with AI-driven Bitcoin treasury solutions, backed by $100 million funding.
Nvidia Invests $2B in Synopsys to Transform Engineering with AI
Nvidia invests $2 billion in Synopsys to accelerate AI-powered design and engineering. Partnership aims to revolutionize product development across semiconductor, aerospace, automotive industries.
Mattress maker Somnigroup Proposes $1.63B All-Stock Deal to Acquire Leggett & Platt
Somnigroup International has offered to acquire Leggett & Platt in a $1.63B all-stock deal, representing a 17% premium. Leggett & Platt’s board is reviewing the unsolicited proposal.